Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF NUCLEAR MEDICINE   SUMMER 2015 , Volume 23 , Number 2 (SERIAL NUMBER 44); Page(s) 103 To 107.
 
Paper: 

EVALUATION OF A NEW 99MTC-BOMBESIN ANALOG IN DIFFERENTIATION OF MALIGNANT FROM BENIGN BREAST TUMORS

 
 
Author(s):  BEIKI DAVOOD, KARAMI FATEMEH, FALLAHI BABAK*, KAVIANI AHMAD, HARIRCHI IRAJ, OMRANIPOUR RAMESH, ERFANI MOSTAFA, FARZANEFAR SAEED, FARD ESFAHANI ARMAGHAN, EMAMI ARDEKANI ALIREZA, SAGHARI MOHSEN, EFTEKHARI MOHAMMAD
 
* SHARIATI HOSPITAL, NORTH KARGAR AVE., TEHRAN, IRAN
 
Abstract: 

Introduction: The gastrin releasing peptide (GRP) receptor is over expressed in a variety of common human tumors. Radiolabeled bombesin analogues have exhibited high binding affinity for these receptors. The aim of this study was to assess the value of a new 99mTc-bombesin analog in the differentiation of malignant from benign breast tumors.
Methods: 99mTc-bombesin scans were performed in 21 patients (45±21years) with breast tumor. Post-injection of 555-740 MBq 99mTc-bombesin, the dynamic imaging of the chest with 60 seconds for each frame up to 20 minutes was acquired. Subsequently, 360o image SPECTs of the chest was performed in 120 steps, 20 seconds per projection. In addition, wholebody anterior and posterior views were obtained 60 and 180 min after injection. Definite diagnosis was based on excisional biopsy and histopathological examination.
Results: Thirteen patients demonstrated breast carcinoma and 8 patients were diagnosed as benign lesions.11 out of 13 patients with breast carcinoma showed radiotracer uptake in the breast lesion. Nine out of 13 patients with breast carcinoma showed axillary lymph node involvement from which only two revealed radiotracer accumulation in the axillary lesion. All patients with benign lesions revealed negative scan. Delayed planar whole body images showed no additional diagnostic information in comparison to one-hour images. The sensitivity, specificity, PPV and NPV of 99mTc-bombesin scan were 84.6%, 100%, 100% and 80%, respectively.
Conclusion: Our data suggest that this new 99mTc-bombesin analog could be useful in SPECT imaging of primary breast cancer.

 
Keyword(s): 99MTC-BOMBESIN, BREAST CANCER, MALIGNANT, IMAGING
 
 
References: 
  • ندارد
  •  
 
Click to Cite.
APA: Copy

BEIKI, D., & KARAMI, F., & FALLAHI, B., & KAVIANI, A., & HARIRCHI, I., & OMRANIPOUR, R., & ERFANI, M., & FARZANEFAR, S., & FARD ESFAHANI, A., & EMAMI ARDEKANI, A., & SAGHARI, M., & EFTEKHARI, M. (2015). EVALUATION OF A NEW 99MTC-BOMBESIN ANALOG IN DIFFERENTIATION OF MALIGNANT FROM BENIGN BREAST TUMORS. IRANIAN JOURNAL OF NUCLEAR MEDICINE, 23(2 (SERIAL NUMBER 44)), 103-107. https://www.sid.ir/en/journal/ViewPaper.aspx?id=509386



Vancouver: Copy

BEIKI DAVOOD, KARAMI FATEMEH, FALLAHI BABAK, KAVIANI AHMAD, HARIRCHI IRAJ, OMRANIPOUR RAMESH, ERFANI MOSTAFA, FARZANEFAR SAEED, FARD ESFAHANI ARMAGHAN, EMAMI ARDEKANI ALIREZA, SAGHARI MOHSEN, EFTEKHARI MOHAMMAD. EVALUATION OF A NEW 99MTC-BOMBESIN ANALOG IN DIFFERENTIATION OF MALIGNANT FROM BENIGN BREAST TUMORS. IRANIAN JOURNAL OF NUCLEAR MEDICINE. 2015 [cited 2021May15];23(2 (SERIAL NUMBER 44)):103-107. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=509386



IEEE: Copy

BEIKI, D., KARAMI, F., FALLAHI, B., KAVIANI, A., HARIRCHI, I., OMRANIPOUR, R., ERFANI, M., FARZANEFAR, S., FARD ESFAHANI, A., EMAMI ARDEKANI, A., SAGHARI, M., EFTEKHARI, M., 2015. EVALUATION OF A NEW 99MTC-BOMBESIN ANALOG IN DIFFERENTIATION OF MALIGNANT FROM BENIGN BREAST TUMORS. IRANIAN JOURNAL OF NUCLEAR MEDICINE, [online] 23(2 (SERIAL NUMBER 44)), pp.103-107. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=509386.



 
  pdf-File
Yearly Visit 107
 
Latest on Blog
Enter SID Blog